Key statistics
On Friday, PTC Therapeutics Inc (PTCT:NSQ) closed at 36.64, -9.95% below its 52-week high of 40.69, set on May 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.20 |
---|---|
High | 37.17 |
Low | 35.22 |
Bid | 14.66 |
Offer | 45.00 |
Previous close | 36.16 |
Average volume | 595.08k |
---|---|
Shares outstanding | 76.92m |
Free float | 75.12m |
P/E (TTM) | -- |
Market cap | 2.82bn USD |
EPS (TTM) | -6.32 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PTC Therapeutics to Participate at Upcoming Investor Conferences
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
- PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
- CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
More ▼